Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 17 (Search time: 0.004 seconds).
previous
1
2
next
Item hits:
Preview
Issue Date
Title
Author(s)
2018
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells
Ross, D.
;
Pagani, I.
;
Shanmuganathan, N.
;
Kok, C.
;
Seymour, J.
;
Mills, A.
;
Filshie, R.
;
Arthur, C.
;
Dang, P.
;
Saunders, V.
;
Braley, J.
;
Yong, A.
;
Yeung, D.
;
White, D.
;
Grigg, A.
;
Schwarer, A.
;
Branford, S.
;
Hughes, T.
2012
Contrasting effects of diclofenac and ibuprofen on active imatinib uptake into leukaemic cells
Wang, J.
;
Hughes, T.
;
Kok, C.
;
Saunders, V.
;
Frede, A.
;
Groot Obbink, K.
;
Osborn, M.
;
Somogyi, A.
;
D'Andrea, R.
;
White, D.
2022
RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid Leukemia.
Shanmuganathan, N.
;
Wadham, C.
;
Thomson, D.
;
Shahrin, N.H.
;
Vignaud, C.
;
Obourn, V.
;
Chaturvedi, S.
;
Yang, F.
;
Feng, J.
;
Saunders, V.
;
Kok, C.H.
;
Yeung, D.
;
King, R.M.
;
Kenyon, R.R.
;
Lin, M.
;
Wang, P.
;
Scott, H.
;
Hughes, T.
;
Schreiber, A.W.
;
Branford, S.
2013
Proton pump inhibitors significantly increase the intracellular concentration of nilotinib, but not imatinib in target CML cells
White, D.
;
Eadie, L.
;
Saunders, V.
;
Hiwase, D.
;
Hughes, T.
2010
Nilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells: implications for combination TKI therapy
Hiwase, D.
;
White, D.
;
Zrim, S.
;
Saunders, V.
;
Vaz de Melo, J.
;
Hughes, T.
2010
Chronic Myeloid Leukemia CD34+ cells have reduced uptake of imatinib due to low OCT-1 Activity
Engler, J.
;
Frede, A.
;
Saunders, V.
;
Zannettino, A.
;
Hughes, T.
;
White, D.
2010
Blocking cytokine signaling along with intense Bcr-Abl kinase inhibition induces apoptosis in primary CML progenitors
Hiwase, D.
;
White, D.
;
Powell, J.
;
Saunders, V.
;
Zrim, S.
;
Frede, A.
;
Guthridge, M.
;
Lopez, A.
;
D'Andrea, R.
;
To, L.
;
Vaz de Melo, J.
;
Kumar, S.
;
Hughes, T.
2010
The poor response to imatinib observed in CML patients with low OCT-1 activity is not attributable to lower uptake of imatinib into their CD34⁺ cells
Engler, J.
;
Frede, A.
;
Saunders, V.
;
Zannettino, A.
;
White, D.
;
Hughes, T.
2006
OCT-1-mediated influx is a key determinant of the intraceflular uptake of imatinib but not nilotinib, (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib
White, D.
;
Saunders, V.
;
Dang, P.
;
Engler, J.
;
Zannettino, A.
;
Cambareri, A.
;
Quinn, S.
;
Manley, P.
;
Hughes, T.
2007
Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity
White, D.
;
Saunders, V.
;
Dang, P.
;
Engler, J.
;
Venables, A.
;
Zrim, S.
;
Zannettino, A.
;
Lynch, K.
;
Manley, P.
;
Hughes, T.
Discover
Author
16
White, D.
7
Dang, P.
7
Frede, A.
5
Engler, J.
5
Hiwase, D.
5
Manley, P.
5
Zrim, S.
4
Zannettino, A.
3
Eadie, L.
3
Kok, C.
.
next >
Subject
11
Humans
9
Leukemia, Myelogenous, Chronic, B...
9
Pyrimidines
8
Imatinib Mesylate
7
Antineoplastic Agents
7
Benzamides
7
Piperazines
5
Organic Cation Transporter 1
4
CML
4
Fusion Proteins, bcr-abl
.
next >
Date issued
1
2020 - 2022
12
2010 - 2019
4
2006 - 2009